Medistim ASA (OSL:MEDI)

Market Cap	4.53B
Revenue (ttm)	662.18M
Net Income (ttm)	142.42M
Shares Out	18.28M
EPS (ttm)	7.79
PE Ratio	31.84
Forward PE	27.86
Dividend	6.00 (2.35%)
Ex-Dividend Date	May 9, 2025

Volume	4,533
Average Volume	7,795
Open	260.00
Previous Close	255.00
Day's Range	248.00 - 260.00
52-Week Range	142.00 - 292.00
Beta	1.19
RSI	48.63
Earnings Date	Apr 9, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: Oslo Børs
• Ticker Symbol: MEDI

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.